Aquestive Therapeutics, Inc.

AQSTNASDAQHealthcare● Active

$3.91

$-0.02(-0.51%)

Market Cap$388288947

P/E Ratio—

52W High$7.55

52W Low$2.93

Avg Volume1.6M

Open$4.00

Beta1.45

Overview

Aquestive Therapeutics, Inc. (AQST) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · AQST · as of Mar 4, 2026

Latest filing snapshot

151

+9+6.34%vs prior year

Aquestive Therapeutics, Inc. (AQST) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

151

Change (1Y)

Growth % (1Y)

+6.34%

Revenue / Employee

$295.0K

Net Income / Employee

$-554.9K

Market Cap

$388M

AQST Employee Count

2018 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-04	2025-12-31	151	+9	+6.34%
2025-03-05	2024-12-31	142	+7	+5.19%
2024-03-05	2023-12-31	135	+5	+3.85%
2023-03-31	2022-12-31	130	-27	-17.20%
2022-03-08	2021-12-31	157	-30	-16.04%
2021-03-09	2020-12-31	187	-45	-19.40%
2020-03-11	2019-12-31	232	-45	-16.25%
2019-03-14	2018-12-31	277	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Drug Manufacturers - Specialty & Generic

#SymbolCompanyEmployeesMkt Cap

EBS

Emergent BioSolutions Inc.

Esperion Therapeutics, Inc.

Aquestive Therapeutics, Inc.YOU

Anavex Life Sciences Corp.

42$243M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · AQST peer comparison

About AQST employees

AQST Employees · Headcount

Aquestive Therapeutics, Inc. (AQST) employee data is sourced from the annual SEC 10-K filing. As of 2025, Aquestive Therapeutics, Inc. had 151 full-time employees globally. Full-time employees only. Global consolidated headcount.

Aquestive Therapeutics, Inc. employs 151 full-time employees as of the latest filing within the Drug Manufacturers - Specialty & Generic industry. Revenue per employee stands at $295,000, reflecting the company's operational efficiency.

Aquestive Therapeutics, Inc.'s workforce increased by 9 (6.34%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Aquestive Therapeutics, Inc.'s revenue per employee of $295,000 positions it among the notable performers in the Drug Manufacturers - Specialty & Generic sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

AQST Employees · 5 questions

As of the latest SEC 10-K filing (2025), Aquestive Therapeutics, Inc. had 151 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Aquestive Therapeutics, Inc. employee counthow many employees does Aquestive Therapeutics, Inc. haveAQST total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-04